MedAdvisor Stock

MedAdvisor EV/FCF

Delisted

The EV/FCF (Enterprise Value to Free Cash Flow) of MedAdvisor (MDR.AX) as of Sep 8, 2026 is -1.36. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 3.29 — a change of -141.51% (lower).

EV/FCF

-1.36

YoY

-141.51%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of MedAdvisor is 2026 -1.36 . EV/FCF (Enterprise Value to Free Cash Flow) of MedAdvisor was 2025 3.29 . It decreases by -141.51% lower compared to the previous year.

The MedAdvisor EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-0.96 AUD
Jan 1, 2019
-1.36 AUD
Jan 1, 2020
-0.33 AUD
Jan 1, 2021
-1.24 AUD
Jan 1, 2022
-36.19 AUD
Jan 1, 2023
-7.90 AUD
Jan 1, 2024
3.29 AUD
Jan 1, 2025
-1.36 AUD
The MedAdvisor EV/FCF history
YEAREV/FCFYoY
-1.36-141.51%
3.29-141.64%
-7.90-78.18%
-36.19+2,824.06%
-1.24+278.00%
-0.33-75.96%
-1.36+41.91%
-0.96-43.22%
-1.69-58.20%
-4.04-85.66%
-28.20+455.21%
-5.08
Access this data via the Eulerpool API

MedAdvisor Stock analysis

What does MedAdvisor do? Medadvisor Ltd is an Australian company that offers a digital platform for healthcare. Founded in 2012 by Robert Read, David Liu, and Josh Swinnerton, their aim was to develop a platform that simplifies medication management for patients, pharmacies, and doctors. Today, Medadvisor is a publicly traded company with a wide range of digital healthcare solutions. They offer various solutions to support patients in medication intake and management, such as a mobile application that allows patients to manage their medications, order prescriptions, and receive reminders. They also offer solutions for pharmacies, including an online ordering system and access to electronic patient history, as well as a platform for doctors to electronically issue prescriptions. One of their latest products is a mobile application that facilitates the handling of COVID-19, providing real-time virus spread tracking and symptom tracking tools. Medadvisor focuses on meeting customer needs and continuously improving the healthcare process. They recently partnered with Take2 Healthcare to expand their range of solutions and create the best offering of health solutions. Overall, Medadvisor plays an important role in the Australian healthcare system by helping their customers live happier and healthier lives through innovative technologies and services. MedAdvisor is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MedAdvisor stock

EV/FCF (Enterprise Value to Free Cash Flow) of MedAdvisor is -1.36 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of MedAdvisor changed from 3.29 to -1.36, representing a -141.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) MedAdvisor since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s MedAdvisor with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — MedAdvisor

All Key Metrics — MedAdvisor